Availability of Non-Exclusive, Exclusive License or Partially Exclusive Licensing of U.S. Patent Concerning Polymerization of Aromatic Monomers Using Derivatives of Hematin, 67921 [E7-23368]
Download as PDF
Federal Register / Vol. 72, No. 231 / Monday, December 3, 2007 / Notices
documents from the General Services
Administration, Regulatory Secretariat
(VIR), 1800 F Street, NW, Room 4035,
Washington, DC 20405, telephone (202)
501–4755. Please cite OMB Control No.
9000–0155, Prohibition on Acquisition
of Products Produced by Forced or
Indentured Child Labor, in all
correspondence.
Dated: November 21, 2007.
Al Matera,
Director, Office of Acquisition Policy.
[FR Doc. 07–5918 Filed 11–30–07; 8:45 am]
BILLING CODE 6820–EP–S
Missile Defense Agency, in consultation
with the Missile Defense Agency Office
of General Counsel, has determined in
writing that the public interest requires
that all sessions of the committee’s
meeting will be closed to the public
because they will be concerned with
classified information and matters
covered by section 5 U.S.C. 552b(c)(1).
Committee’s Designated Federal
Officer: Mr. Al Bready, mdac@mda.mil,
phone/voice mail 703–695–6438, or
mail at 7100 Defense Pentagon,
Washington, DC 20301–7100.
Pursuant
to 41 CFR 102–3.105(j) and 102–3.140,
and section 10(a)(3) of the Federal
Advisory Committee Act of 1972, the
public or interested organizations may
submit written statements to the
membership of the Missile Defense
Advisory Committee about its mission
and functions. Written statements may
be submitted at any time or in response
to the stated agenda of a planned
meeting of the Missile Defense Advisory
Committee.
All written statements shall be
submitted to the Designated Federal
Officer for the Missile Defense Advisory
Committee, in the following formats:
one hard copy with original signature
and one electronic copy via e-mail
(acceptable file formats: Adobe Acrobat
PDF, MS Word or MS PowerPoint), and
this individual will ensure that the
written statements are provided to the
membership for their consideration.
Contact information for the Designated
Federal Officer is as stated above and
can also be obtained from the GSA’s
Federal Advisory Committee Act
Database—https://www.fido.gov/
facadatabase/public.asp.
Statements being submitted in
response to the agenda mentioned in
this notice must be received by the
Designated Federal Officer at the
address listed at least five calendar days
prior to the meeting which is the subject
of this notice. Written statements
received after this date may not be
provided to or considered by the Missile
Defense Advisory Committee until its
next meeting. The Designated Federal
Officer will review all timely
submissions with the Missile Defense
Advisory Committee Chairperson and
ensure they are provided to all members
of the Missile Defense Advisory
Committee before the meeting that is the
subject of this notice.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF DEFENSE
Office of the Secretary of Defense
Missile Defense Advisory Committee
Department of Defense; Missile
Defense Agency (MDA).
ACTION: Notice of Closed Meeting.
mstockstill on PROD1PC66 with NOTICES
AGENCY:
SUMMARY: Under the provisions of the
Federal Advisory Committee Act of
1972 (5 U.S.C., Appendix, as amended)
and the Government in the Sunshine
Act of 1976 (5 U.S.C. 552b, as amended)
and 41 CFR 102–3.150, the Department
of Defense announces that the following
Federal advisory committee meeting
will take place.
Name of Committee: Missile Defense
Advisory Committee.
Dates of Meeting: Wednesday,
December 19 and Thursday, December
20, 2007.
Time: 8 a.m. to 5 p.m. Security
clearance and visit requests are required
for access.
Location: 7100 Defense Pentagon,
Washington, DC 20301–7100.
Purpose of the Meeting: At this
meeting, the Committee will receive
classified briefings by Missile Defense
Agency senior staff, Program Managers,
senior Department of Defense leaders,
representatives from industry and the
Services on the appropriate role for the
Missile Defense Agency in Cruise
Missile Defense.
Agenda: Topics tentatively scheduled
for discussion include, but are not
limited to administrative work;
responsibilities for Cruise Missile
Defense development; current Missile
Defense Agency Cruise Missile Defense
capabilities and responsibilities; review
of governing directives; and Cruise
Missile Defense capabilities
development programs for the Services.
Meeting Accessibility: Pursuant to 5
U.S.C. 552b, as amended, and 41 CFR
102–3.155 the Missile Defense Agency
has determined that the meeting shall be
closed to the public. The Director,
VerDate Aug<31>2005
16:17 Nov 30, 2007
Jkt 214001
Mr.
Al Bready, Designated Federal Officer at
mdac@mda.mil, phone/voice mail 703–
695–6438, or mail at 7100 Defense
Pentagon, Washington, DC 20301–7100.
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
67921
Dated: November 27, 2007.
L.M. Bynum,
Alternate OSD Federal Register, Liaison
Officer, Department of Defense.
[FR Doc. E7–23333 Filed 11–30–07; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF DEFENSE
Department of the Army
Availability of Non-Exclusive,
Exclusive License or Partially
Exclusive Licensing of U.S. Patent
Concerning Polymerization of
Aromatic Monomers Using Derivatives
of Hematin
Department of the Army, DoD.
Notice.
AGENCY:
ACTION:
SUMMARY: In accordance with 37 CFR
404.6, announcement is made of the
availability for licensing of U.S. Patent
No. U.S. 7,294,686 entitled
‘‘Polymerization of Aromatic Monomers
Using Derivatives of Hematin’’ issued
November 13, 2007. This patent has
been assigned to the United States
Government as represented by the
Secretary of the Army.
FOR FURTHER INFORMATION CONTACT: Mr.
Jeffrey DiTullio at U.S. Army Soldier
Systems Center, Kansas Street, Natick,
MA 01760, Phone; (508) 233–4184 or Email: Jeffrey.Ditullio@natick.army.mil.
SUPPLEMENTARY INFORMATION: Any
licenses granted shall comply with 35
U.S.C. 209 and 37 CFR part 404.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. E7–23368 Filed 11–30–07; 8:45 am]
BILLING CODE 3710–08–P
DEPARTMENT OF DEFENSE
Department of the Army
Mandatory Provision of Full
Replacement Value Coverage by
Department of Defense Personal
Property Transportation Service
Providers (TSPs)/Contractors
Department of the Army, DOD.
Notice.
AGENCY:
ACTION:
SUMMARY: This cancels the notice
previously published in the Federal
Register on December 15, 2006 (71 FR
75509). Pursuant to Chapter 157,
§ 2636a of Title 10 United States Code
enacted by Congress on November 26,
2003, as amended by the Department of
Defense Authorizations Act for FY 2007,
the Military Surface Deployment and
Distribution Command (SDDC), as the
E:\FR\FM\03DEN1.SGM
03DEN1
Agencies
[Federal Register Volume 72, Number 231 (Monday, December 3, 2007)]
[Notices]
[Page 67921]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-23368]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Department of the Army
Availability of Non-Exclusive, Exclusive License or Partially
Exclusive Licensing of U.S. Patent Concerning Polymerization of
Aromatic Monomers Using Derivatives of Hematin
AGENCY: Department of the Army, DoD.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the
availability for licensing of U.S. Patent No. U.S. 7,294,686 entitled
``Polymerization of Aromatic Monomers Using Derivatives of Hematin''
issued November 13, 2007. This patent has been assigned to the United
States Government as represented by the Secretary of the Army.
FOR FURTHER INFORMATION CONTACT: Mr. Jeffrey DiTullio at U.S. Army
Soldier Systems Center, Kansas Street, Natick, MA 01760, Phone; (508)
233-4184 or E-mail: Jeffrey.Ditullio@natick.army.mil.
SUPPLEMENTARY INFORMATION: Any licenses granted shall comply with 35
U.S.C. 209 and 37 CFR part 404.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. E7-23368 Filed 11-30-07; 8:45 am]
BILLING CODE 3710-08-P